Efficacy and tolerability of a β-1 selective β blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study

Debashish Mitra; K D Tibrewala; M Somasundaram; R K Marya; V Channaraya

首页> 外文期刊>BMJ Open >Efficacy and tolerability of a β-1 selective β blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study

【24h】

Efficacy and tolerability of a β-1 selective β blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study

机译：β-1选择性β受体阻滞剂比索洛尔作为诊断为原发性高血压（BRIGHT）的印度患者一线降压药的疗效和耐受性：一项开放性，多中心观察性研究

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《BMJ Open》 |2012年第3期|共页
作者
Debashish Mitra; K D Tibrewala; M Somasundaram; R K Marya; V Channaraya;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献

1. Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in japanese patients with grade I or II essential hypertension: Randomized, double-blind, placebo-controlled study [J] . MatsuokaH., KuwajimaI., ShimadaK., The journal of clinical hypertension. . 2013,第11期

机译：比索洛尔透皮贴剂（TY-0201）和富马酸比索洛尔口服制剂在日本I级或II级原发性高血压患者中的疗效和安全性比较：随机，双盲，安慰剂对照研究
2. Antihypertensive efficacy of metoprolol XL/low dose chlorthalidone (6.25 mg) combination: a randomized, comparative study in indian patients with mild-to-moderate essential hypertension. [J] . Pareek A, Zawar SD, Salagre SB European journal of medical research. . 2009,第7期

机译：美托洛尔XL /低剂量氯噻酮（6.25 mg）组合的抗高血压功效：对印度轻度至中度原发性高血压患者的一项随机对照研究。
3. Antihypertensive efficacy of metoprolol XL/Low dose chlorthalidone (6.25 mg) combination: a randomized, comparative study in Indian patients with mild-to-moderate essential hypertension [J] . A Pareek, SD Zawar, SB Salagre, European journal of medical research. . 2009,第7期

机译：美托洛尔XL /小剂量氯噻酮（6.25 mg）组合的抗高血压功效：对印度轻度至中度原发性高血压患者的一项随机对照研究
4. Efficacy and tolerability of a β-1 selective β blocker bisoprolol as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label multicentric observational study [O] . V Channaraya, R K Marya, M Somasundaram, 2012

机译：β-1选择性β受体阻滞剂比索洛尔作为诊断为原发性高血压（BRIGHT）的印度患者的一线降压药的疗效和耐受性：一项开放性多中心观察性研究
5. Efficacy and tolerability of a β-1 selective β blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study [O] . Channaraya, V, Marya, R K, Somasundaram, M, 2012

机译：β-1选择性β受体阻滞剂比索洛尔作为诊断为原发性高血压（BRIGHT）的印度患者的一线降压药的疗效和耐受性：一项开放性，多中心观察性研究

Efficacy and tolerability of a β-1 selective β blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study

著录项

相似文献

相关主题

期刊订阅